[Code of Federal Regulations] [Title 21, Volume 8] [Revised as of April 1, 2006] From the U.S. Government Printing Office via GPO Access [CITE: 21CFR809.3] [Page 84] TITLE 21--FOOD AND DRUGS CHAPTER I--FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) PART 809_IN VITRO DIAGNOSTIC PRODUCTS FOR HUMAN USE--Table of Contents Subpart A_General Provisions Sec. 809.3 Definitions. Subpart A_General Provisions Sec. 809.3 Definitions. 809.4 Confidentiality of submitted information. Subpart B_Labeling 809.10 Labeling for in vitro diagnostic products. Subpart C_Requirements for Manufacturers and Producers 809.20 General requirements for manufacturers and producers of in vitro diagnostic products. 809.30 Restrictions on the sale, distribution and use of analyte specific reagents. 809.40 Restrictions on the sale, distribution, and use of OTC test sample collection systems for drugs of abuse testing. Authority: 21 U.S.C. 331, 351, 352, 355, 360b, 360c, 360d, 360h, 360i, 360j, 371, 372, 374, 381. (a) In vitro diagnostic products are those reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body. These products are devices as defined in section 201(h) of the Federal Food, Drug, and Cosmetic Act (the act), and may also be biological products subject to section 351 of the Public Health Service Act. (b) A product class is all those products intended for use for a particular determination or for a related group of determinations or products with common or related characteristics or those intended for common or related uses. A class may be further divided into subclasses when appropriate. (c) [Reserved] (d) Act means the Federal Food, Drug, and Cosmetic Act. [41 FR 6903, Feb. 13, 1976, as amended at 45 FR 7484, Feb. 1, 1980]